Insider · CIK 0001283535

Patou Gary

CIK 0001283535 Name as filed on the most recent filing

Filed as Patou Gary (60)

102 transaction lines · from 60 filings · filed 2004-11-04 to 2026-06-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

102 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-05 S, Open-market sale Xenon Pharmaceuticals Inc.XENE 70,251, disposed Open Form 4 filing 0001193125-26-262672
2024-11-22 S, Open-market sale Xenon Pharmaceuticals Inc.XENE 2 lines 200,947, disposed Open Form 4 filing 0000950170-24-130378
2023-12-14 S, Open-market sale Xenon Pharmaceuticals Inc.XENE 311,898, disposed Open Form 4 filing 0000950170-23-070912
2023-12-13 S, Open-market sale Xenon Pharmaceuticals Inc.XENE 4 lines 758,983, disposed Open Form 4 filing 0000950170-23-070841
2022-11-25 S, Open-market sale Xenon Pharmaceuticals Inc.XENE 67,390, disposed Open Form 4 filing 0001209191-22-058916
2022-11-23 S, Open-market sale Xenon Pharmaceuticals Inc.XENE 70,610, disposed Open Form 4 filing 0001209191-22-058916
2017-08-10 P, Open-market purchase Xenon Pharmaceuticals Inc.XENE 20,836, acquired Open Form 4 filing 0001171843-17-005072
2017-08-08 P, Open-market purchase Xenon Pharmaceuticals Inc.XENE 15,003, acquired Open Form 4 filing 0001171843-17-004960
2014-08-07 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2,005,200, disposed Open Form 4 filing 0001209191-14-051439
2014-07-14 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 2,582,639, disposed Open Form 4 filing 0001209191-14-047123
2014-05-12 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 750,000, disposed Open Form 4 filing 0001209191-14-033456
2014-05-09 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 1,481,600, disposed Open Form 4 filing 0001209191-14-033456
2013-10-01 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 978,400, disposed Open Form 4 filing 0001209191-13-047530
2013-07-02 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 300,000, disposed Open Form 4 filing 0001209191-13-034931
2013-07-01 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 877,500, disposed Open Form 4 filing 0001209191-13-034931
2013-04-12 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 300,000, disposed Open Form 4 filing 0001209191-13-021463
2013-04-01 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 844,591, disposed Open Form 4 filing 0001209191-13-020013
2006-05-31 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 25,200, disposed Open Form 4 filing 0001181431-06-034849
2006-05-22 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 39,900, disposed Open Form 4 filing 0001181431-06-032221
2006-04-26 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 42,750, disposed Open Form 4 filing 0001181431-06-025804
2006-04-25 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 43,750, disposed Open Form 4 filing 0001181431-06-025804
2006-03-30 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 19,800, disposed Open Form 4 filing 0001181431-06-021057
2006-03-21 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 21,500, disposed Open Form 4 filing 0001181431-06-019374
2006-03-20 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 2 lines 41,800, disposed Open Form 4 filing 0001181431-06-019374
2006-03-03 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 21,000, disposed Open Form 4 filing 0001181431-06-016716
2006-02-27 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 2 lines 19,300, disposed Open Form 4 filing 0001181431-06-015393
2006-02-10 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 31,500, disposed Open Form 4 filing 0001181431-06-011393
2006-02-07 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 57,250, disposed Open Form 4 filing 0001181431-06-009985
2006-01-27 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 21,500, disposed Open Form 4 filing 0001181431-06-006927
2006-01-12 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 25,000, disposed Open Form 4 filing 0001181431-06-003850
2006-01-09 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 3 lines 77,158, disposed Open Form 4 filing 0001181431-06-003191
2006-01-03 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 34,200, disposed Open Form 4 filing 0001181431-06-001266
2005-11-29 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 15,228, disposed Open Form 4 filing 0001181431-05-063790
2005-11-28 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 10,000, disposed Open Form 4 filing 0001181431-05-063790
2005-11-18 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 2 lines 10,418, disposed Open Form 4 filing 0001181431-05-062612
2005-11-17 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 2 lines 28,750, disposed Open Form 4 filing 0001181431-05-062612
2005-10-31 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 26,850, disposed Open Form 4 filing 0001181431-05-059194
2005-10-25 S, Open-market sale Oscient Pharmaceuticals CorpOSCI 19,000, disposed Open Form 4 filing 0001181431-05-058103

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 100
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. PATOU GARY, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001283535

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.